4Schabitz WR,Kollmar R.Schwaninger M,et al.Neuroprotective effect of granuiocyte colony-stimulating factor after focal cerebral ischemia.Stoke,2003,34(3):745-751.
5Corti S,Locatelli F,Strazzer S,et al.Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment.Exp Neural,2002,177(2):443-452.
6Yannaki E,Athanasiou E,Xagorari A,et al.G-CSF primed hematopoietic stem cells or G-CSF per seaccelerate recovery and improve survival after liver injury,predominantly by promoting endogenous repair programs.Exp Hemotol,2005,33(1):108-109.
7Tigue CC, McKoy JM, Evens AM, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007;40(3):185-192.
8de la Rubia J, de Arriba F, Arbona C, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008; 93(5):735-740.
9Cesaro S, Marson P, Gazzola MV, et al. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Haematologica. 2002;87(8 Suppl):35-41.
10Michael A, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-3611.
